Skip to main content Accessibility help

First Onset of Schizophrenia

  • David L. Dunner


  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.



Hide All

Disclosure: Dr. Dunner is a consultant to Bristol-Myers Squibb, Corcept, Cypress, Eli Lilly, GlaxoSmithKline, Janssen, Novartis, Otsuka, Pfizer, Shire, Somerset, and Wyeth; is on the speakers bureaus of Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Organon, Pfizer, and Wyeth.

Funding/Support: Dr. Dunner has received grant support from Cyberonics, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Pfizer, and Wyeth.

First Onset of Schizophrenia

  • David L. Dunner


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed